WO2002002627A3 - Interferon-like protein zcyto21 - Google Patents

Interferon-like protein zcyto21 Download PDF

Info

Publication number
WO2002002627A3
WO2002002627A3 PCT/US2001/021087 US0121087W WO0202627A3 WO 2002002627 A3 WO2002002627 A3 WO 2002002627A3 US 0121087 W US0121087 W US 0121087W WO 0202627 A3 WO0202627 A3 WO 0202627A3
Authority
WO
WIPO (PCT)
Prior art keywords
interferon
zcyto21
protein
polypeptides
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/021087
Other languages
French (fr)
Other versions
WO2002002627A2 (en
Inventor
Paul O Sheppard
Scott R Presnell
Brian A Fox
Teresa Gilbert
Betty A Haldeman
Francis J Grant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26910034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002002627(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to DE60128093T priority Critical patent/DE60128093T2/en
Priority to EP01950827A priority patent/EP1294888B1/en
Priority to BR0112119-7A priority patent/BR0112119A/en
Priority to JP2002507878A priority patent/JP4377126B2/en
Priority to DK06012489T priority patent/DK1717316T3/en
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU2001271786A priority patent/AU2001271786A1/en
Priority to CA2413258A priority patent/CA2413258C/en
Priority to DK01950827T priority patent/DK1294888T3/en
Publication of WO2002002627A2 publication Critical patent/WO2002002627A2/en
Anticipated expiration legal-status Critical
Publication of WO2002002627A3 publication Critical patent/WO2002002627A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.
PCT/US2001/021087 2000-06-30 2001-06-29 Interferon-like protein zcyto21 Ceased WO2002002627A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DK01950827T DK1294888T3 (en) 2000-06-30 2001-06-29 Interferon-like protein Zcyto21
EP01950827A EP1294888B1 (en) 2000-06-30 2001-06-29 Interferon-like protein zcyto21
BR0112119-7A BR0112119A (en) 2000-06-30 2001-06-29 Isolated polypeptide, isolated nucleic acid molecule, vector, recombinant host cell, method of producing zcyto21 protein, antibody or antibody fragment, method of detecting presence of zcyto21 gene expression in a biological sample
JP2002507878A JP4377126B2 (en) 2000-06-30 2001-06-29 Interferon-like protein ZCYTO21
DK06012489T DK1717316T3 (en) 2000-06-30 2001-06-29 Allelic variant of interferon-like protein Zcyto21
DE60128093T DE60128093T2 (en) 2000-06-30 2001-06-29 INTERFERON-SIMILAR PROTEIN ZCYTO21
AU2001271786A AU2001271786A1 (en) 2000-06-30 2001-06-29 Interferon-like protein zcyto21
CA2413258A CA2413258C (en) 2000-06-30 2001-06-29 Interferon-like protein zcyto21

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21544600P 2000-06-30 2000-06-30
US60/215,446 2000-06-30
US28542401P 2001-04-20 2001-04-20
US60/285,424 2001-04-20

Publications (2)

Publication Number Publication Date
WO2002002627A2 WO2002002627A2 (en) 2002-01-10
WO2002002627A3 true WO2002002627A3 (en) 2003-01-03

Family

ID=26910034

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021087 Ceased WO2002002627A2 (en) 2000-06-30 2001-06-29 Interferon-like protein zcyto21

Country Status (13)

Country Link
US (18) US6927040B2 (en)
EP (4) EP1294888B1 (en)
JP (1) JP4377126B2 (en)
CN (1) CN100448993C (en)
AT (2) ATE404670T1 (en)
AU (1) AU2001271786A1 (en)
BR (1) BR0112119A (en)
CA (1) CA2413258C (en)
DE (2) DE60135393D1 (en)
DK (2) DK1717316T3 (en)
ES (2) ES2286128T3 (en)
RU (1) RU2292394C2 (en)
WO (1) WO2002002627A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927040B2 (en) * 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US7910313B2 (en) 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
WO2002092762A2 (en) * 2001-05-10 2002-11-21 Immunex Corporation Cytokine polypeptides
US6902930B2 (en) * 2001-08-29 2005-06-07 Vanderbilt University Human Mob-5 (IL-24) receptors and uses thereof
WO2003066002A2 (en) 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
EP2295455A1 (en) 2002-04-19 2011-03-16 ZymoGenetics, L.L.C. Cytokine receptor
EP1529108A2 (en) * 2002-08-07 2005-05-11 ZLB Behring GmbH Albumin-fused ciliary neurotrophic factor
EP1575609A4 (en) * 2002-10-23 2010-12-15 Zymogenetics L L C Methods for treating viral infection using il-28 and il-29
EP1927600A1 (en) 2003-08-07 2008-06-04 Zymogenetics, Inc. Homogeneous preparations of IL-28 and IL-29
WO2005097165A2 (en) * 2004-04-02 2005-10-20 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
CA2574564C (en) * 2004-07-29 2013-04-16 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer and autoimmune disorders
RU2389502C2 (en) * 2004-07-29 2010-05-20 Займодженетикс, Инк. Application of il-28 and il-29 for treatment carcinoma and autoimmune disorders
US20060178301A1 (en) * 2005-02-04 2006-08-10 Mathias Jurs Albumin-fused ciliary neurotrophic factor
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
JP2009502803A (en) * 2005-07-20 2009-01-29 ザイモジェネティクス， インコーポレイテッド Cysteine deletion mutants of IL-28 and IL-29, and antiviral methods using the same
WO2007041713A1 (en) * 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
TW200744634A (en) * 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
EP3103813A1 (en) 2007-12-07 2016-12-14 ZymoGenetics, Inc. Anti-human il-21 monoclonal antibodies
US10071154B2 (en) * 2008-04-04 2018-09-11 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
JP2011522834A (en) * 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Use of pegylated type III interferon for the treatment of hepatitis C
WO2010045261A1 (en) * 2008-10-13 2010-04-22 Zymogenetics, Llc Single chain fc type iii interferons and methods of using same
CN102858691B (en) 2010-04-28 2015-09-23 株式会社村田制作所 Perovskite material with anion-controlled dielectric properties, thin film capacitor device and method of fabrication thereof
FR2975185A1 (en) * 2011-05-12 2012-11-16 Univ Claude Bernard Lyon METHOD FOR IN VITRO DETERMINATION OF THE PRESENCE OF A MULTIPLE SCLEROSIS
RU2549710C2 (en) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Method for purifying recombinant protein of type iii interferon-like factor
CN102998450B (en) * 2012-11-22 2014-10-15 北京正旦国际科技有限责任公司 Immuno-mass spectrometric detection kit for esophagus cancer
US10246501B2 (en) 2014-01-08 2019-04-02 Prosit Sole Biotechnology (Beijing) Co, Ltd Fusion polypeptides and methods of use
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
WO2016172342A1 (en) 2015-04-21 2016-10-27 Eiger Biopharmaceuticals, Inc. Pharmaceutical compositions comprising lonafarnib and ritonavir
JP7674628B2 (en) 2016-02-19 2025-05-12 イーアイティー・ファーマ・インコーポレイテッド Treatment of hepatitis delta virus infection with interferon lambda.
WO2018064574A1 (en) * 2016-09-30 2018-04-05 The Board Of Trustees Of The Leland Stanford Junior University Variant type iii interferons and synthekines

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000213A1 (en) 1980-01-04 1981-07-09 Zahnfabrik Wienand Söhne & Co GmbH, 6072 Dreieich METHOD FOR PRODUCING A CROSSLINKED POLYMER FOR DENTAL PURPOSES
IE54096B1 (en) 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
IE54046B1 (en) 1981-08-25 1989-05-24 Celltech Ltd Expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4496778A (en) * 1983-10-03 1985-01-29 Exxon Research & Engineering Co. Process for the hydroxylation of olefins using molecular oxygen, an osmium containing catalyst, a copper Co-catalyst, and an aromatic amine based promoter
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4990446A (en) 1984-12-06 1991-02-05 Labofina, S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and use thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
ES2136092T3 (en) * 1991-09-23 1999-11-16 Medical Res Council PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES.
US5700638A (en) * 1993-08-26 1997-12-23 Washington University Cell death regulator
US6451578B1 (en) * 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
SK100896A3 (en) 1994-02-14 1997-10-08 Zymogenetics Inc Hematopoietic protein and materials and methods for making it
US5641655A (en) 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
US5679715A (en) * 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
US5716808A (en) 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US6025539A (en) * 1996-04-09 2000-02-15 Mayo Foundation For Medical Education And Research IL-5 transgenic mouse
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
JP2001524801A (en) * 1996-07-09 2001-12-04 ジェネティックス・インスチチュート・インコーポレーテッド Secreted proteins and polynucleotides encoding them
US5854039A (en) 1996-07-17 1998-12-29 Zymogenetics, Inc. Transformation of pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US5985614A (en) 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
EP1500329B1 (en) 1996-12-03 2012-03-21 Amgen Fremont Inc. Human antibodies that specifically bind human TNF alpha
GB9702944D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Reducing fibrosis
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
WO1999046379A2 (en) 1998-03-09 1999-09-16 Schering Corporation Human receptor proteins; related reagents and methods
WO1999054458A1 (en) * 1998-04-17 1999-10-28 Whitehead Institute For Biomedical Research Use of a ribozyme to join nucleic acids and peptides
AR021876A1 (en) * 1998-12-18 2002-08-07 Schering Corp COMBINATION THERAPY FOR HCV INDUCTION OF RIBAVIRINA - INTERFERON ALFA PEGILADO
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
US6927040B2 (en) * 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
WO2002092762A2 (en) 2001-05-10 2002-11-21 Immunex Corporation Cytokine polypeptides
JP3939160B2 (en) * 2001-05-25 2007-07-04 独立行政法人科学技術振興機構 Methods for expressing foreign genes in the kidney
WO2003066002A2 (en) 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
EP1575609A4 (en) 2002-10-23 2010-12-15 Zymogenetics L L C Methods for treating viral infection using il-28 and il-29
EP1927600A1 (en) 2003-08-07 2008-06-04 Zymogenetics, Inc. Homogeneous preparations of IL-28 and IL-29
WO2005097165A2 (en) 2004-04-02 2005-10-20 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
JP2011522834A (en) 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Use of pegylated type III interferon for the treatment of hepatitis C
WO2010045261A1 (en) 2008-10-13 2010-04-22 Zymogenetics, Llc Single chain fc type iii interferons and methods of using same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL SEQUENCE LIBRARY [online] 15 December 1999 (1999-12-15), MUZNY D.M., ADAMS C., ET AL.: "Homo sapiens chromosome 19 clone RP11-67A5, WORKING DRAFT SEQUENCE, 14 unordered pieces", XP002202437, retrieved from HTTP://SRS6.EBI.AC.UK/SRS6BIN/CGI-BIN/WGETZ?-E+[EM Database accession no. AC018477 *
DATABASE EMBL SEQUENCE LIBRARY [online] 2 September 1993 (1993-09-02), ADAMS M.D., KERLAVAGE A.R., FIELDS C., VENTER J.C.: "3,400 expressed sequence tags identify diversity of transcripts from human brain"", XP002202435, retrieved from HTTP://SRS6.EBI.AC.UK/SRS6BIN/CGI-BIN/WGETZ?-E+[EM Database accession no. T07139 *
DATABASE EMBL SEQUENCE LIBRARY [online] 8 October 1999 (1999-10-08), DOE JOINT GENOME INSTITUTE STANFORD HUMAN GENOME CENTER: "Homo sapiens chromosome 19 clone CTC-246B18, complete sequence", XP002202436, retrieved from HTTP://SRS6.EBI.AC.UK/SRS6BIN/CGI-BIN/WGETZ?-E+[EM Database accession no. AC011445 *

Also Published As

Publication number Publication date
US20120036590A1 (en) 2012-02-09
US7485700B2 (en) 2009-02-03
US6927040B2 (en) 2005-08-09
US20100222266A1 (en) 2010-09-02
US20050106680A1 (en) 2005-05-19
CA2413258C (en) 2012-01-03
CN100448993C (en) 2009-01-07
US20070049736A1 (en) 2007-03-01
JP2004502419A (en) 2004-01-29
US20080214788A1 (en) 2008-09-04
US20090326204A1 (en) 2009-12-31
US20050106682A1 (en) 2005-05-19
US20040146988A1 (en) 2004-07-29
US20020039763A1 (en) 2002-04-04
EP1294888B1 (en) 2007-04-25
EP1294888A2 (en) 2003-03-26
US7241870B2 (en) 2007-07-10
DE60128093D1 (en) 2007-06-06
ATE404670T1 (en) 2008-08-15
US20120258458A1 (en) 2012-10-11
US7253261B2 (en) 2007-08-07
US7655223B2 (en) 2010-02-02
WO2002002627A2 (en) 2002-01-10
US20070043209A1 (en) 2007-02-22
EP2132984A3 (en) 2010-11-03
CN1443240A (en) 2003-09-17
DK1294888T3 (en) 2007-08-20
DE60135393D1 (en) 2008-09-25
ES2311253T3 (en) 2009-02-01
US7498154B2 (en) 2009-03-03
US20090069274A1 (en) 2009-03-12
EP1717316A1 (en) 2006-11-02
EP1717316B1 (en) 2008-08-13
US20080102490A1 (en) 2008-05-01
RU2292394C2 (en) 2007-01-27
US7445913B2 (en) 2008-11-04
US7833520B2 (en) 2010-11-16
ES2286128T3 (en) 2007-12-01
EP2132984A2 (en) 2009-12-16
US20110172170A1 (en) 2011-07-14
BR0112119A (en) 2003-05-06
US20070048841A1 (en) 2007-03-01
AU2001271786A1 (en) 2002-01-14
EP1939293A3 (en) 2008-07-09
ATE360696T1 (en) 2007-05-15
DK1717316T3 (en) 2008-12-08
RU2003103099A (en) 2005-01-20
US7252969B2 (en) 2007-08-07
DE60128093T2 (en) 2007-12-27
CA2413258A1 (en) 2002-01-10
EP1939293A2 (en) 2008-07-02
US20070042468A1 (en) 2007-02-22
US20050014228A1 (en) 2005-01-20
US7919595B2 (en) 2011-04-05
JP4377126B2 (en) 2009-12-02
US20110054148A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
WO2002002627A3 (en) Interferon-like protein zcyto21
EA199900355A1 (en) TELOMERASE REVERSE TRINCRYPTASE
ATE349700T1 (en) TRANSITION METAL COMPLEX CONTAINING LUMINESCENT PROTEIN COLORS
WO2003020932A1 (en) Novel secretory proteins and dna thereof
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
WO2002038592A3 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
WO2002086087A3 (en) Cytokine protein family
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
DK0968288T3 (en) z219a, a human homolog for 2-19 protein
DE69925116D1 (en) NEW, PHYSIOLOGICAL ACTIVE PEPTIDES AND THEIR USE.
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2003082897A3 (en) Synthetic active peptide fragments
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
WO2003033675A3 (en) Identification of binding partners for specific proteins
WO2002036633A3 (en) Human 7tm proteins and polynucleotides encoding the same
WO2002016435A3 (en) Human 7tm proteins and polynucleotides encoding the same
TH43074A (en) Glucose Dehydrogenase Binding Protein And its use in characterization systems
WO2001036644A3 (en) Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
ZA91699B (en) Antibodies specifically recognizing somatotropin binding protein
WO2001085937A3 (en) Regulator of g protein signalling (rgs8)
EA199900663A1 (en) NEW PROTEINS CONNECTING WITH RECEPTOR 1 INTERFERON, ENCODING THEIR DNA AND METHODS OF MODULATION OF CELLULAR RESPONSE TO INTERFERON
WO2002098900A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2413258

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001950827

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 108/CHENP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 018131530

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2003103099

Country of ref document: RU

Kind code of ref document: A

Ref country code: RU

Ref document number: RU A

WWP Wipo information: published in national office

Ref document number: 2001950827

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001950827

Country of ref document: EP